Vectura Group Plc manufactures novel therapeutic products and drug delivery systems. It engages in developing inhaled therapies principally for the treatment of respiratory diseases. The company's main products target diseases such as asthma and chronic obstructive pulmonary disease. It is engaged in a single business activity of pharmaceuticals, which consists of the research, development and commercialisation of pharmaceutical products. The company was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.